ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SXTP vs JUNS // FREE CASH FLOW YIELD

60 Degrees Pharmaceuticals Inc. (NASDAQ) VS. Jupiter Neurosciences Inc. (NASDAQ) • 15-METRIC TALLY: SXTP 3 — JUNS 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SXTP VS. JUNS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SXTP JUNS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 22.30% 80.60% -58.30 JUNS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 65.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 SXTP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.6 32.2 +16.42 SXTP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.3M $3.1M $207.5K SXTP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SXTP REV JUNS REV SXTP GROSS % JUNS GROSS % SXTP FCF JUNS FCF
FY 2025 $1.0M $21.8K 22.3% 80.6% -$7.0M -$5.4M
FY 2024 $607.6K $0 36.7% — -$5.8M -$3.9M
FY 2023 $253.6K $0 — — -$4.5M -$481.0K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SXTP // BETA —
JUNS // BETA —